Pathology of Prostate Cancer and Focal Therapy ('Male Lumpectomy')

Mazzucchelli R., Scarpelli M., Cheng L., Lopez-Beltran A., Galosi A. B., Kirkali Z., ...Daha Fazla

ANTICANCER RESEARCH, cilt.29, sa.12, ss.5155-5161, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 29 Sayı: 12
  • Basım Tarihi: 2009
  • Dergi Adı: ANTICANCER RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.5155-5161
  • Anahtar Kelimeler: Prostate cancer, focal therapy, male lumpectomy, review, PREDICTING TUMOR VOLUME, PRIMARY GLEASON PATTERN, RADICAL PROSTATECTOMY, PREOPERATIVE PREDICTION, INDEPENDENT PREDICTOR, DISEASE PROGRESSION, PROGNOSTIC-FACTORS, PATIENT SELECTION, ABLATIVE THERAPY, NEEDLE-BIOPSY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Focal therapy of the prostate is defined as prostate gland ablation aiming at eradication of unifocal low-risk prostate cancer, and preserving uninvolved (peri-) prostatic tissue and therefore quality of life. The major arguments against focal therapy can be classified under the headings of understaging and multifocality. The argument of understaging highlights the importance of the occasional, but troublesome, finding of a large, extraprostatic or high-grade tumor (Gleason score 17) in about a quarter of radical prostatectomy sped. mens removed from men initially classified as having a low-risk tumor. Indeed, 85% of all prostate cancer cases arc multifocal. These concerns can be offset by additional testing: another biopsy, especially a transperineal mapping biopsy, and magnetic resonance imaging (MRI) of the prostate. The technology nee(led to ablate small regions or sectors of the prostate harboring a known cancer is rapidly becoming available. Cryotherapy is already being used and the preliminary data arc encouraging, Ultrasound-guided high-intensity focused ultrasound (HIFU), photodynamic therapy using newly developed light-sensitizing agents, and MRI-guided HIFU are all promising new tools.